DK1249450T3 - Benzimidazolderivater som human chymase-inhibitorer - Google Patents
Benzimidazolderivater som human chymase-inhibitorerInfo
- Publication number
- DK1249450T3 DK1249450T3 DK01901397T DK01901397T DK1249450T3 DK 1249450 T3 DK1249450 T3 DK 1249450T3 DK 01901397 T DK01901397 T DK 01901397T DK 01901397 T DK01901397 T DK 01901397T DK 1249450 T3 DK1249450 T3 DK 1249450T3
- Authority
- DK
- Denmark
- Prior art keywords
- halo
- optionally substituted
- oxo
- trihalomethyl
- alk
- Prior art date
Links
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title abstract 3
- 101000909983 Homo sapiens Chymase Proteins 0.000 title abstract 2
- 239000003601 chymase inhibitor Substances 0.000 title abstract 2
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 6
- 125000004953 trihalomethyl group Chemical group 0.000 abstract 4
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 abstract 3
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 3
- 125000004043 oxo group Chemical group O=* 0.000 abstract 3
- 125000004951 trihalomethoxy group Chemical group 0.000 abstract 3
- WMNWZTLQAKKZDD-UHFFFAOYSA-N 4-[1-[(1,4-dimethylindol-3-yl)methyl]benzimidazol-2-yl]sulfanylbutanoic acid Chemical compound OC(=O)CCCSC1=NC2=CC=CC=C2N1CC1=CN(C)C2=C1C(C)=CC=C2 WMNWZTLQAKKZDD-UHFFFAOYSA-N 0.000 abstract 2
- -1 5-oxo-1,2,4-thiadiazol-3-yl Chemical group 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000004442 acylamino group Chemical group 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 150000001556 benzimidazoles Chemical class 0.000 abstract 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 229940119334 Chymase inhibitor Drugs 0.000 abstract 1
- 241000700159 Rattus Species 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000007533 | 2000-01-17 | ||
| JP2000392303 | 2000-12-25 | ||
| PCT/JP2001/000271 WO2001053291A1 (en) | 2000-01-17 | 2001-01-17 | Benzimidazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1249450T3 true DK1249450T3 (da) | 2008-02-11 |
Family
ID=26583615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01901397T DK1249450T3 (da) | 2000-01-17 | 2001-01-17 | Benzimidazolderivater som human chymase-inhibitorer |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1249450B1 (sl) |
| JP (1) | JP4059671B2 (sl) |
| KR (2) | KR100763779B1 (sl) |
| CN (2) | CN100415723C (sl) |
| AT (1) | ATE375156T1 (sl) |
| AU (2) | AU777813B2 (sl) |
| CA (1) | CA2396908A1 (sl) |
| CZ (1) | CZ301504B6 (sl) |
| DE (1) | DE60130865T2 (sl) |
| DK (1) | DK1249450T3 (sl) |
| ES (1) | ES2295128T3 (sl) |
| IL (1) | IL150565A0 (sl) |
| NO (1) | NO324049B1 (sl) |
| NZ (1) | NZ520028A (sl) |
| PT (1) | PT1249450E (sl) |
| RU (1) | RU2263674C2 (sl) |
| SI (1) | SI1249450T1 (sl) |
| WO (1) | WO2001053291A1 (sl) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100457750C (zh) * | 2001-02-22 | 2009-02-04 | 帝人株式会社 | 苯并[b]噻吩衍生物及其制备方法 |
| US6774245B2 (en) * | 2001-05-07 | 2004-08-10 | Teijin Limited | 3-Hydroxymethylbenzo[b]thiophene derivatives and process for their preparation |
| KR100902799B1 (ko) * | 2001-08-24 | 2009-06-12 | 데이진 가부시키가이샤 | 키마제 저해제 및 ａｃｅ 저해제를 유효성분으로 함유하는약제 |
| CL2004001034A1 (es) | 2003-05-14 | 2005-03-28 | Teijin Pharma Ltd | Formas cristalinas de acido 4-(1-((,etilbenzotiofen-3-il)me til)benzimidazol-2-iltio)butanoico; procedimiento de preparacion de las formas cristalinas; composicion farmaceutica; y su uso para el tratamiento de enfermedades inflamatorias, alergicas, r |
| JP4387360B2 (ja) * | 2003-08-22 | 2009-12-16 | 帝人ファーマ株式会社 | キマーゼ阻害剤を有効成分として含有する薬剤 |
| US20080015240A1 (en) * | 2004-11-12 | 2008-01-17 | Mitsuru Teramoto | Acid Salt of Benzimidazole Derivative and Crystal Thereof |
| EP1915988A4 (en) | 2005-08-18 | 2012-07-25 | Teijin Pharma Ltd | COMPRESSOR COMPRISING MULTIPLE SEGMENTS CONTAINING MEDICAMENTS |
| KR20080034517A (ko) | 2005-08-18 | 2008-04-21 | 데이진 화-마 가부시키가이샤 | 정확한 용량 분할 기능을 갖는 제제 |
| CN101296919A (zh) | 2005-10-27 | 2008-10-29 | 帝人制药株式会社 | 苯并[b]噻吩衍生物极其制备方法 |
| WO2007049812A1 (ja) | 2005-10-27 | 2007-05-03 | Teijin Pharma Limited | ３－ヒドロキシメチルベンゾ［ｂ］チオフェン誘導体およびその製造方法 |
| PE20070698A1 (es) | 2005-11-14 | 2007-08-17 | Teijin Pharma Ltd | Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol |
| UA95788C2 (en) * | 2005-12-15 | 2011-09-12 | Ф. Хоффманн-Ля Рош Аг | Fused pyrrole derivatives |
| JP5268120B2 (ja) | 2007-05-22 | 2013-08-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ベンゾイミダゾロンキマーゼ阻害薬 |
| TWI443090B (zh) | 2007-05-25 | 2014-07-01 | Abbvie Deutschland | 作為代謝性麩胺酸受體２（ｍｇｌｕ２ 受體）之正向調節劑之雜環化合物 |
| WO2008153129A1 (ja) * | 2007-06-14 | 2008-12-18 | Teijin Pharma Limited | 尿酸値低下剤 |
| WO2009133964A1 (ja) * | 2008-04-28 | 2009-11-05 | 国立大学法人九州大学 | 酸化ストレス抑制剤 |
| EP2364313B1 (en) * | 2008-09-09 | 2014-01-08 | Boehringer Ingelheim International GmbH | Aza-benzimidazolone chymase inhibitors |
| CA2737694C (en) | 2008-09-26 | 2013-07-02 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| MX2011004258A (es) | 2008-10-22 | 2011-06-01 | Merck Sharp & Dohme | Derivados de bencimidazol ciclicos novedosos utiles como agentes anti-diabeticos. |
| AU2009309007A1 (en) | 2008-10-29 | 2010-05-06 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| WO2010051206A1 (en) | 2008-10-31 | 2010-05-06 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| CA2777746C (en) * | 2009-11-18 | 2019-05-14 | Astrazeneca Ab | Benzoimidazole compounds and uses thereof |
| WO2011106273A1 (en) | 2010-02-25 | 2011-09-01 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| WO2012116145A1 (en) | 2011-02-25 | 2012-08-30 | Merck Sharp & Dohme Corp. | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| CN104603127B (zh) * | 2012-05-04 | 2016-10-05 | 诺华股份有限公司 | 补体途径调节剂及其应用 |
| WO2014022528A1 (en) | 2012-08-02 | 2014-02-06 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| EP2888008B1 (en) | 2012-08-22 | 2018-12-26 | Merck Sharp & Dohme Corp. | Novel azabenzimidazole tetrahydrofuran derivatives |
| WO2014031441A1 (en) | 2012-08-22 | 2014-02-27 | Merck Sharp & Dohme Corp. | Novel benzimidazole tetrahydrofuran derivatives |
| WO2014031445A1 (en) | 2012-08-22 | 2014-02-27 | Merck Sharp & Dohme Corp. | Novel benzimidazole tetrahydropyran derivatives |
| WO2014031465A1 (en) | 2012-08-22 | 2014-02-27 | Merck Sharp & Dohme Corp. | Novel azabenzimidazole tetrahydropyran derivatives |
| JP2015526468A (ja) | 2012-08-22 | 2015-09-10 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | 新規なアザベンズイミダゾールヘキサヒドロフロ［３，２−ｂ］フラン誘導体 |
| ES2755087T3 (es) | 2012-08-22 | 2020-04-21 | Merck Sharp & Dohme | Derivados de benzimidazol hexahidrofuro[3,2-b]furano útiles como activadores de proteína cinasa activada por AMP |
| EP2970119B1 (en) | 2013-03-14 | 2021-11-03 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
| WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| EP3068768B1 (en) | 2013-11-15 | 2019-07-31 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| WO2015089809A1 (en) | 2013-12-19 | 2015-06-25 | Merck Sharp & Dohme Corp. | Antidiabetic substituted heteroaryl compounds |
| CN111004125B (zh) * | 2019-12-24 | 2022-11-22 | 东华理工大学 | 一种缩醛或缩酮化合物的制备方法 |
| CN116903541B (zh) * | 2023-08-14 | 2023-12-08 | 中国环境科学研究院 | 用于酚类污染物检测的酰基咪唑类化合物、制备方法及应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2430950A1 (fr) * | 1978-07-10 | 1980-02-08 | Delalande Sa | Nouveaux derives heterocycliques de la benzimidazole, leur procede de preparation et leur application en therapeutique |
| DE2928055A1 (de) * | 1978-07-12 | 1980-01-31 | Eastman Kodak Co | Verfahren zur verbesserung der widerstandsfaehigkeit von polyesterformkoerpern gegenueber einem abbau durch u.v.- licht |
| JPS62212386A (ja) * | 1986-03-14 | 1987-09-18 | Suntory Ltd | ２−ピリジルメチルベンズイミダゾ−ル誘導体 |
| JPH01265089A (ja) * | 1988-04-15 | 1989-10-23 | Zeria Pharmaceut Co Ltd | 新規１−（イミダゾール−４−イル）メチルベンズイミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤 |
| GB9225141D0 (en) * | 1992-12-01 | 1993-01-20 | Smithkline Beecham Corp | Chemical compounds |
| NO306992B1 (no) * | 1993-01-28 | 2000-01-24 | Takeda Chemical Industries Ltd | Quinolinderivater, farmasoeytiske preparater inneholdende forbindelsene og anvendelsen av forbindelsene |
| US5527597A (en) * | 1995-03-01 | 1996-06-18 | Southern Mills, Inc. | Stretchable flame resistant fabric |
| WO1999026932A1 (en) * | 1997-11-26 | 1999-06-03 | Axys Pharmaceuticals, Inc. | By amidino group substituted heterocyclic derivatives and their use as anticoagulants |
| HUP0103256A3 (en) * | 1998-07-15 | 2002-05-28 | Teijin Ltd | Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds |
| CZ20014573A3 (cs) * | 1999-06-28 | 2002-05-15 | Janssen Pharmaceutica N. V. | Inhibitory replikace respiračně syncyciálního viru |
| CZ2001153A3 (cs) * | 1999-07-14 | 2001-06-13 | Teijin Ltd | Thiobenzimidazolové deriváty |
-
2001
- 2001-01-17 CZ CZ20022442A patent/CZ301504B6/cs not_active IP Right Cessation
- 2001-01-17 EP EP01901397A patent/EP1249450B1/en not_active Expired - Lifetime
- 2001-01-17 ES ES01901397T patent/ES2295128T3/es not_active Expired - Lifetime
- 2001-01-17 WO PCT/JP2001/000271 patent/WO2001053291A1/ja not_active Ceased
- 2001-01-17 DE DE60130865T patent/DE60130865T2/de not_active Expired - Lifetime
- 2001-01-17 RU RU2002122105/04A patent/RU2263674C2/ru not_active IP Right Cessation
- 2001-01-17 KR KR1020027009200A patent/KR100763779B1/ko not_active Expired - Fee Related
- 2001-01-17 NZ NZ520028A patent/NZ520028A/en unknown
- 2001-01-17 AU AU27049/01A patent/AU777813B2/en not_active Ceased
- 2001-01-17 DK DK01901397T patent/DK1249450T3/da active
- 2001-01-17 PT PT01901397T patent/PT1249450E/pt unknown
- 2001-01-17 AT AT01901397T patent/ATE375156T1/de not_active IP Right Cessation
- 2001-01-17 SI SI200130792T patent/SI1249450T1/sl unknown
- 2001-01-17 KR KR1020077010650A patent/KR20070057276A/ko not_active Abandoned
- 2001-01-17 JP JP2001553765A patent/JP4059671B2/ja not_active Expired - Fee Related
- 2001-01-17 CN CNB2005100526041A patent/CN100415723C/zh not_active Expired - Fee Related
- 2001-01-17 CA CA002396908A patent/CA2396908A1/en not_active Abandoned
- 2001-01-17 CN CNB018066623A patent/CN1198819C/zh not_active Expired - Fee Related
- 2001-01-17 IL IL15056501A patent/IL150565A0/xx not_active IP Right Cessation
-
2002
- 2002-07-16 NO NO20023415A patent/NO324049B1/no not_active IP Right Cessation
-
2005
- 2005-01-14 AU AU2005200172A patent/AU2005200172B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| NO20023415D0 (no) | 2002-07-16 |
| KR20020065929A (ko) | 2002-08-14 |
| HK1050009A1 (en) | 2003-06-06 |
| CN1198819C (zh) | 2005-04-27 |
| PT1249450E (pt) | 2008-01-02 |
| CN100415723C (zh) | 2008-09-03 |
| EP1249450A1 (en) | 2002-10-16 |
| ES2295128T3 (es) | 2008-04-16 |
| CN1680339A (zh) | 2005-10-12 |
| AU2704901A (en) | 2001-07-31 |
| NO324049B1 (no) | 2007-08-06 |
| RU2263674C2 (ru) | 2005-11-10 |
| DE60130865D1 (de) | 2007-11-22 |
| NZ520028A (en) | 2004-07-30 |
| CA2396908A1 (en) | 2001-07-26 |
| KR100763779B1 (ko) | 2007-10-05 |
| IL150565A0 (en) | 2003-02-12 |
| KR20070057276A (ko) | 2007-06-04 |
| SI1249450T1 (sl) | 2008-04-30 |
| AU2005200172B2 (en) | 2007-08-23 |
| NO20023415L (no) | 2002-07-16 |
| CZ301504B6 (cs) | 2010-03-24 |
| AU777813B2 (en) | 2004-11-04 |
| EP1249450B1 (en) | 2007-10-10 |
| CN1418211A (zh) | 2003-05-14 |
| RU2002122105A (ru) | 2004-01-10 |
| ATE375156T1 (de) | 2007-10-15 |
| EP1249450A4 (en) | 2003-04-09 |
| AU2005200172A1 (en) | 2005-02-10 |
| JP4059671B2 (ja) | 2008-03-12 |
| WO2001053291A1 (en) | 2001-07-26 |
| DE60130865T2 (de) | 2008-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1249450T3 (da) | Benzimidazolderivater som human chymase-inhibitorer | |
| ES2625944T3 (es) | Inhibidores de tirosina cinasa de Bruton | |
| NO20062004L (no) | Forlenget frigjoring farmasoytiske blandinger omfattene aplindor og derivater derav | |
| ATE384052T1 (de) | Pyrimidin-2-on-verbindungen und ihre verwendung als dopamin-d3-rezeptorliganden | |
| PL356766A1 (en) | Stable salts of novel derivatives of 3,3-diphenylpropylamines | |
| NO20063080L (no) | Azepinoindolderivater som farmasoytiske midler | |
| ATE540938T1 (de) | Neue benzoxazinonderivate als langwirksame betamimetika zur behandlung von atemwegserkrankungen | |
| RU2003136097A (ru) | Производные фенилпиридинкарбонилпиперазина | |
| YU68102A (sh) | Derivati karboksilne kiseline kao ip antagonisti | |
| RU2010147918A (ru) | 5-метил-1-(нафталин-2-ил)-1н-пиразолы в качестве ингибиторов сигма-рецепторов | |
| ECSP055644A (es) | Derivados de la quinolil-propil-piperidina y su utilización | |
| TW200504085A (en) | Derivatives of [2-(8,9-dioxo-2, 6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of use thereof | |
| DE69401584D1 (de) | Beta,beta-dimethyl-4-piperidinethanamin-derivate als inhibitoren der cholesterin-biosynthese | |
| EA200501104A1 (ru) | Производные пиридина, пригодные для ингибирования системы обмена натрия/кальция | |
| NO20062617L (no) | Anvendelse av glukosidase inhibitorer for terapi av mucovisidose | |
| JP2011510072A5 (sl) | ||
| CY1110465T1 (el) | Υποκατεστημενα παραγωγα ιμιδαζολινης | |
| NO20074622L (no) | Metabolitter for NK-1 antagonister for brekninger | |
| PT1709027E (pt) | Compostos do tipo hidrazida e sua utilização em composições farmacêuticas para o tratamento de doenças cardiovasculares | |
| CA2422807A1 (en) | N-substituted benzothiophenesulfonamide derivatives | |
| ES2172436A1 (es) | Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. | |
| DE69414396D1 (de) | Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten | |
| NO20060277L (no) | Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger | |
| BR0108251A (pt) | Derivado de pirrolopiridazina ou um sal deste farmaceuticamente aceitável, composição farmacêutica, agente contendo um derivado de pirrolopiridazina ou um sal deste farmaceuticamente aceitável, e, uso de um derivado de pirrolopiridazina ou um sal deste farmaceuticamente aceitável | |
| JPH083044A (ja) | 骨粗鬆症の予防または治療剤 |